Literature DB >> 28490787

The changing face of polyarteritis nodosa and necrotizing vasculitis.

Seza Ozen1.   

Abstract

Polyarteritis nodosa (PAN) is a vasculitic disease characterized primarily by necrotizing vasculitis - inflammatory lesions in blood vessels that lead to vessel wall necrosis. Our understanding of PAN and necrotizing vasculitis has evolved over time. In addition to PAN, necrotizing vasculitis is now a recognized feature of a broad range of diseases with different aetiopathogenesis. For example, necrotizing vasculitis associated with hepatitis B virus infection has a different aetiopathogeneis to PAN and is now classified as a separate disease. Additionally, although 'classic' PAN is not an inherited disease, mutations in specific genes, such as ADA2 (also known as CECR1), can result in a necrotizing vasculopathy similar to PAN. The literature also suggests that the course of PAN differs in childhood-onset disease and in cases confined to the skin (so-called cutaneous PAN). Dissecting PAN and other autoinflammatory diseases with PAN-like features has enabled more-specific therapies and might also help us better understand the pathogenesis of these devastating conditions.

Entities:  

Mesh:

Year:  2017        PMID: 28490787     DOI: 10.1038/nrrheum.2017.68

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  49 in total

Review 1.  TAP deficiency syndrome.

Authors:  S D Gadola; H T Moins-Teisserenc; J Trowsdale; W L Gross; V Cerundolo
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

Review 2.  L1. Pathogenesis of ANCA-associated vasculitis: observations, theories and speculations.

Authors:  J Charles Jennette; Ronald J Falk
Journal:  Presse Med       Date:  2013-03-01       Impact factor: 1.228

Review 3.  L17. What can we expect from the revised Chapel Hill consensus conference nomenclature of vasculitis?

Authors:  J Charles Jennette
Journal:  Presse Med       Date:  2013-02-26       Impact factor: 1.228

4.  Are carriers for MEFV mutations "healthy"?

Authors:  M Kalyoncu; B C Acar; N Cakar; A Bakkaloglu; S Ozturk; E Dereli; M Tunca; O Kasapcopur; F Yalcinkaya; S Ozen
Journal:  Clin Exp Rheumatol       Date:  2006 Sep-Oct       Impact factor: 4.473

5.  Clinical observation of 14 cases of childhood polyarteritis nodosa in Japan.

Authors:  M Maeda; M Kobayashi; S Okamoto; T Fuse; T Matsuyama; N Watanabe; S Fujikawa
Journal:  Acta Paediatr Jpn       Date:  1997-04

6.  EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria.

Authors:  Seza Ozen; Angela Pistorio; Silvia M Iusan; Aysin Bakkaloglu; Troels Herlin; Riva Brik; Antonella Buoncompagni; Calin Lazar; Ilmay Bilge; Yosef Uziel; Donato Rigante; Luca Cantarini; Maria Odete Hilario; Clovis A Silva; Mauricio Alegria; Ximena Norambuena; Alexandre Belot; Yackov Berkun; Amparo Ibanez Estrella; Alma Nunzia Olivieri; Maria Giannina Alpigiani; Ingrida Rumba; Flavio Sztajnbok; Lana Tambic-Bukovac; Luciana Breda; Sulaiman Al-Mayouf; Dimitrina Mihaylova; Vyacheslav Chasnyk; Claudia Sengler; Maria Klein-Gitelman; Djamal Djeddi; Laura Nuno; Chris Pruunsild; Jurgen Brunner; Anuela Kondi; Karaman Pagava; Silvia Pederzoli; Alberto Martini; Nicolino Ruperto
Journal:  Ann Rheum Dis       Date:  2010-05       Impact factor: 19.103

7.  Clinical Spectrum of Medium-Sized Vessel Vasculitis.

Authors:  Fatma Alibaz-Oner; Matthew J Koster; Cynthia S Crowson; Ashima Makol; Steven R Ytterberg; Carlo Salvarani; Eric L Matteson; Kenneth J Warrington
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-04-24       Impact factor: 4.794

8.  Prevalence of the MEFV gene mutations in childhood polyarteritis nodosa.

Authors:  Fatoş Yalçinkaya; Z Birsin Ozçakar; Ozgür Kasapçopur; Ayşenur Oztürk; Nejat Akar; Ayşin Bakkaloğlu; Nil Arisoy; Mesiha Ekim; Seza Ozen
Journal:  J Pediatr       Date:  2007-08-28       Impact factor: 4.406

9.  Diagnostic criteria for polyarteritis nodosa in childhood.

Authors:  S Ozen; N Besbas; U Saatci; A Bakkaloglu
Journal:  J Pediatr       Date:  1992-02       Impact factor: 4.406

10.  Expanding the spectrum of recombination-activating gene 1 deficiency: a family with early-onset autoimmunity.

Authors:  Lauren A Henderson; Francesco Frugoni; Gregory Hopkins; Helen de Boer; Sung-Yun Pai; Yu Nee Lee; Jolan E Walter; Melissa M Hazen; Luigi D Notarangelo
Journal:  J Allergy Clin Immunol       Date:  2013-07-24       Impact factor: 10.793

View more
  21 in total

1.  Thoracic mass lesion in a 14-year-old girl: Answers.

Authors:  Cuneyt Karagol; Fatma Aydın; Özge Başaran; Banu Çelikel Acar; Hasan Ali Durmaz; Nilgün Çakar
Journal:  Pediatr Nephrol       Date:  2021-01-11       Impact factor: 3.714

Review 2.  Childhood- Versus Adult-Onset Primary Vasculitides: Are They Part of the Same Clinical Spectrum?

Authors:  Renato Ferrandiz-Espadin; Manuel Ferrandiz-Zavaler
Journal:  Curr Rheumatol Rep       Date:  2019-08-29       Impact factor: 4.592

Review 3.  Polyarteritis nodosa and deficiency of adenosine deaminase 2 - Shared genealogy, generations apart.

Authors:  Zhengping Huang; Tianwang Li; Peter A Nigrovic; Pui Y Lee
Journal:  Clin Immunol       Date:  2020-04-07       Impact factor: 3.969

Review 4.  What's new in autoinflammation?

Authors:  Seza Ozen
Journal:  Pediatr Nephrol       Date:  2018-12-14       Impact factor: 3.714

5.  [Update: polyarteritis nodosa].

Authors:  Jan H Schirmer; Frank Moosig
Journal:  Z Rheumatol       Date:  2018-06       Impact factor: 1.372

Review 6.  Differentiation of idiopathic pulmonary hemosiderosis from rheumatologic and autoimmune diseases causing diffuse alveolar hemorrhage: establishing a diagnostic approach.

Authors:  Biplab K Saha; Woon H Chong; Nils T Milman
Journal:  Clin Rheumatol       Date:  2021-09-07       Impact factor: 3.650

Review 7.  Deficiency of Adenosine Deaminase 2 (DADA2), an Inherited Cause of Polyarteritis Nodosa and a Mimic of Other Systemic Rheumatologic Disorders.

Authors:  Hasan Hashem; Susan J Kelly; Nancy J Ganson; Michael S Hershfield
Journal:  Curr Rheumatol Rep       Date:  2017-10-05       Impact factor: 4.592

8.  Biologics for childhood systemic vasculitis.

Authors:  Keiji Akamine; Marilynn Punaro
Journal:  Pediatr Nephrol       Date:  2018-09-10       Impact factor: 3.714

9.  A retrospective study comparing the phenotype and outcomes of patients with polyarteritis nodosa between UK and Turkish cohorts.

Authors:  Omer Karadag; Abdulsamet Erden; Yelda Bilginer; Seerapani Gopaluni; Alper Sari; Berkan Armagan; Ihsan Ertenli; Seza Ozen; David Jayne
Journal:  Rheumatol Int       Date:  2018-08-11       Impact factor: 3.580

Review 10.  Vasculitis Pathogenesis: Can We Talk About Precision Medicine?

Authors:  Seza Ozen; Ezgi Deniz Batu
Journal:  Front Immunol       Date:  2018-08-14       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.